Literature DB >> 2300537

Effects of first-pass metabolism on metabolite mean residence time determination after oral administration of parent drug.

K K Chan1, M Gibaldi.   

Abstract

Metabolite kinetics after oral drug administration can be determined, without separate metabolite administration, using the concepts of mean residence time (MRT). The MRT of parent drug and metabolite after oral administration of the parent drug, MRTp,p(oral) and MRTm,p(oral), can be calculated directly from the drug and metabolite profiles. The difference between MRTm,p(oral) and MRTp,p(oral), termed Delta MRT, yields an estimate of MRT of metabolite when the metabolite is given as an iv bolus, MRTm,m(iv). The calculation is simple for drugs that are known to undergo, negligible first-pass metabolism. Correction can also be made when extent of first-pass metabolism is known. Ambiguity is encountered, however, when the degree of first-pass metabolism is unknown. When the delta MRT is negative, then first-pass metabolism must be considered. A positive value of delta MRT, on the other hand, is not a definitive indication of the absence of first-pass metabolism. It may occur in the presence or absence of first-pass metabolism. Ignoring the possibility of first-pass metabolism when a positive value of delta MRT occurs may lead to an incorrect estimate of MRTm,m(iv). The estimation error is relatively small, however, when MRTm,m(iv) much greater than MRTp,p(iv), even when first-pass metabolism is extensive. This situation may apply to the administration of a prodrug.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2300537     DOI: 10.1023/a:1015887626171

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  12 in total

1.  Theory of the mean absorption time, an adjunct to conventional bioavailability studies.

Authors:  D J Cutler
Journal:  J Pharm Pharmacol       Date:  1978-08       Impact factor: 3.765

2.  A simple method for obtaining the mean residence time of metabolites in the body.

Authors:  P Veng-Pedersen
Journal:  J Pharm Sci       Date:  1986-08       Impact factor: 3.534

3.  A method for evaluating the mean residence times of metabolites in the body, systemic circulation, and the peripheral tissue not requiring separate i.v. administration of metabolite.

Authors:  P Veng-Pedersen; W R Gillespie
Journal:  Biopharm Drug Dispos       Date:  1987 Jul-Aug       Impact factor: 1.627

4.  Mean time and first-pass metabolism.

Authors:  D Brockmeier; J Ostrowski
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

5.  Computation of model-independent pharmacokinetic parameters during multiple dosing.

Authors:  L A Bauer; M Gibaldi
Journal:  J Pharm Sci       Date:  1983-08       Impact factor: 3.534

6.  Mean residence time in peripheral tissue: a linear disposition parameter useful for evaluating a drug's tissue distribution.

Authors:  P Veng-Pedersen; W Gillespie
Journal:  J Pharmacokinet Biopharm       Date:  1984-10

7.  Noncompartmental determination of the steady-state volume of distribution for any mode of administration.

Authors:  D Perrier; M Mayersohn
Journal:  J Pharm Sci       Date:  1982-03       Impact factor: 3.534

8.  The mean residence time of drugs in the systemic circulation.

Authors:  P Veng-Pedersen; W Gillespie
Journal:  J Pharm Sci       Date:  1985-07       Impact factor: 3.534

9.  Statistical moments in pharmacokinetics.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-12

10.  The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time.

Authors:  S Riegelman; P Collier
Journal:  J Pharmacokinet Biopharm       Date:  1980-10
View more
  2 in total

Review 1.  Mean residence time of oral drugs undergoing first-pass and linear reversible metabolism.

Authors:  H Cheng; W J Jusko
Journal:  Pharm Res       Date:  1993-01       Impact factor: 4.200

2.  Site-differential gastrointestinal absorption of benazepril hydrochloride in healthy volunteers.

Authors:  K K Chan; A Buch; R D Glazer; V A John; W H Barr
Journal:  Pharm Res       Date:  1994-03       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.